PD-L2 BIOMARKERS PREDICTIVE OF PD-1 PATHWAY INHIBITOR RESPONSES IN ESOPHAGOGASTRIC CANCERS
摘要
The present invention is based on the identification of novel biomarkers predictive of responsiveness of esophagogastric cancers to inhibitors of the PD-1 pathway.
申请公布号
WO2016144673(A1)
申请公布日期
2016.09.15
申请号
WO2016US20589
申请日期
2016.03.03
申请人
DANA-FARBER CANCER INSTITUTE, INC.
发明人
BASS, Adam;DERKS, Sarah;FREEMAN, Gordon, J.;RODIG, Scott, J.
